European survey on preanalytical sample handling - Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)

被引:43
作者
Cadamuro, Janne [1 ]
Lippi, Giuseppe [2 ]
von Meyer, Alexander [3 ,4 ,5 ,6 ]
Ibarz, Mercedes [7 ]
van Dongen-Lases, Edmee [8 ]
Cornes, Michael [9 ]
Nybo, Mads [10 ]
Vermeersch, Pieter [11 ]
Grankvist, Kjell [12 ]
Guimaraes, Joao Tiago [13 ]
Kristensen, Gunn B. B. [14 ]
de la Salle, Barbara [15 ]
Simundic, Ana-Maria [16 ]
机构
[1] Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria
[2] Univ Verona, Sect Clin Chem, Verona, Italy
[3] Kliniken Nordoberpfalz AG, Inst Lab Med, Weiden, Germany
[4] Kliniken Nordoberpfalz AG, Inst Lab Med, Amberg, Germany
[5] Klinikum St Marien, Weiden, Germany
[6] Klinikum St Marien, Amberg, Germany
[7] Univ Hosp Arnau de Vilanova, IRBLleida, Dept Lab Med, Lleida, Spain
[8] Univ Amsterdam, Amsterdam UMC, Dept Clin Chem, Amsterdam, Netherlands
[9] Worcestershire Acute Hosp NHS Trust, Clin & Chem Dept, Worcester, England
[10] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark
[11] Univ Hosp Leuven, Clin Dept Lab Med, Leuven, Belgium
[12] Umea Univ, Dept Med Biosci Clin Chem, Umea, Sweden
[13] Univ Porto, Fac Med, Sao Joao Hosp Ctr, Dept Biomed,Dept Clin Pathol, Porto, Portugal
[14] Norwegian Qual Improvement Lab Examinat Noklus, Bergen, Norway
[15] West Hertfordshire Hosp NHS Trust, Operating UK NEQAS Haematol & Transfus, UK NEQAS Haematol, Watford, England
[16] Univ Hosp Sveti Duh, Dept Med Lab Diagnost, Zagreb, Croatia
关键词
preanalytics; standardization; survey; INTERFERENCE; SPECIMENS; QUALITY; ERRORS; HEMOGLOBIN; BILIRUBIN; REDUCE; INDEX;
D O I
10.11613/BM.2019.020705
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Introduction: No guideline currently exists on how to detect or document haemolysis, icterus or lipemia (HIL) in blood samples, nor on subsequent use of this information. The EFLM WG-PRE has performed a survey for assessing current practices of European laboratories in HIL monitoring. This second part of two coherent articles is focused on HIL. Materials and methods: An online survey, containing 39 questions on preanalytical issues, was disseminated among EFLM member countries. Seventeen questions exclusively focused on assessment, management and follow-up actions of HIL in routine blood samples. Results: Overall, 1405 valid responses from 37 countries were received. A total of 1160 (86%) of all responders stating to analyse blood samples-monitored HIL. HIL was mostly checked in clinical chemistry samples and less frequently in those received for coagulation, therapeutic drug monitoring and serology/infectious disease testing. HIL detection by automatic HIL indices or visual inspection, along with haemolysis cut-offs definition, varied widely among responders. A quarter of responders performing automated HIL checks used internal quality controls. In haemolytic/icteric/lipemic samples, most responders (70%) only rejected HIL-sensitive parameters, whilst about 20% released all test results with general comments. Other responders did not analysed but rejected the entire sample, while some released all tests, without comments. Overall, 26% responders who monitored HIL were using this information for monitoring phlebotomy or sample transport quality. Conclusion: Strategies for monitoring and treating haemolytic, icteric or lipemic samples are quite heterogeneous in Europe. The WG-PRE will use these insights for developing and providing recommendations aimed at harmonizing strategies across Europe.
引用
收藏
页码:334 / 345
页数:12
相关论文
共 40 条
[1]   Introduction [J].
不详 .
DIABETES CARE, 2015, 38 :S1-S2
[2]  
[Anonymous], 2012, 15189 ISO EN
[3]  
Cadamuro J., 2018, J LAB PRECIS MED, V3, P40, DOI [10.21037/jlpm.2018.04.04, DOI 10.21037/JLPM.2018.04.04]
[4]   European survey on preanalytical sample handling - Part 1: How do European laboratories monitor the preanalytical phase? On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) [J].
Cadamuro, Janne ;
Lippi, Giuseppe ;
von Meyer, Alexander ;
Ibarz, Mercedes ;
van Dongen-Lases, Edmee ;
Cornes, Michael ;
Nybo, Mads ;
Vermeersch, Pieter ;
Grankvist, Kjell ;
Guimaraes, Joao Tiago ;
Kristensen, Gunn B. B. ;
de la Salle, Barbara ;
Simundic, Ana-Maria .
BIOCHEMIA MEDICA, 2019, 29 (02) :322-333
[5]   To report or not to report: a proposal on how to deal with altered test results in hemolytic samples [J].
Cadamuro, Janne ;
Mrazek, Cornelia ;
Haschke-Becher, Elisabeth ;
Sandberg, Sverre .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (08) :1109-1111
[6]   A pragmatic approach to sample acceptance and rejection [J].
Cadamuro, Janne ;
Simundic, Ana-Maria ;
Ajzner, Eva ;
Sandberg, Sverre .
CLINICAL BIOCHEMISTRY, 2017, 50 (10-11) :579-581
[7]   Hemolysis rates in blood samples: differences between blood collected by clinicians and nurses and the effect of phlebotomy training [J].
Cadamuro, Janne ;
von Meyer, Alexander ;
Wiedemann, Helmut ;
Felder, Thomas Klaus ;
Moser, Franziska ;
Kipman, Ulrike ;
Haschke-Becher, Elisabeth ;
Mrazek, Cornelia ;
Simundic, Ana-Maria .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (12) :1987-1992
[8]   Errors in a stat laboratory: Types and frequencies 10 years later [J].
Carraro, Paolo ;
Plebani, Mario .
CLINICAL CHEMISTRY, 2007, 53 (07) :1338-1342
[9]  
CLSI, 2005, EP7A2 CLSI
[10]   Correction and reporting of potassium results in haemolysed samples [J].
Dimeski, G ;
Clague, AE ;
Hickman, PE .
ANNALS OF CLINICAL BIOCHEMISTRY, 2005, 42 :119-123